Should we address the course as well as the origin of a translocated anomalous coronary artery?

M D Black1, B W McCrindle, R M Freedom

  • 1Division of Cardiovascular Surgery, The Hospital for Sick Children and The University of Toronto, Ontario, Canada. michael.black@mailhub.sickkids.on.ca

Insights

An anomalous left coronary artery originating from the pulmonary artery requires immediate surgery. A new surgical technique using aortic and pulmonary artery flaps effectively repairs this congenital heart defect, improving outcomes.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Pediatric Cardiac Surgery

Background:

  • Anomalous left coronary artery arising from the pulmonary artery (ALCAPA) is a rare congenital heart defect.
  • ALCAPA leads to myocardial infarction, ischemia, and left ventricular dysfunction, often presenting in infancy.
  • Timely surgical intervention is critical for survival and preventing irreversible heart damage.

Purpose of the Study:

  • To describe a novel surgical modification for repairing ALCAPA.
  • To address both the origin and the course of the anomalous coronary artery.
  • To improve upon existing surgical techniques for ALCAPA repair.

Main Methods:

  • A surgical technique combining autogenous aortic and pulmonary artery flaps was employed.
  • The repair focused on reconstructing the coronary artery's origin and ensuring a proper anatomical course.
  • This modification was applied to cases of ALCAPA originating from the left facing pulmonary sinus.

Main Results:

  • The described surgical modification effectively rerouted the anomalous left coronary artery.
  • The technique addressed the coronary artery's origin and course, a previously overlooked aspect in some repairs.
  • Successful repair aims to restore normal coronary artery perfusion and prevent myocardial damage.

Conclusions:

  • The described surgical technique offers a viable option for ALCAPA repair.
  • Addressing both origin and course of the anomalous artery is crucial for optimal surgical outcomes.
  • This modification represents an advancement in the surgical management of ALCAPA.

Related Concept Videos

Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...